Your session is about to expire
← Back to Search
EEG Monitoring for Drug Overdose
N/A
Waitlist Available
Led By Patrick L Purdon, Ph.D.
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult patients aged 18 years and older who present to the ED with suspected use of a potential drug of abuse
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights
Study Summary
This trial will study whether the EEG could be used to identify drug effects in suspected overdose patients in the ED setting.
Who is the study for?
This trial is for adults over 18 who come to the emergency department suspected of using drugs or alcohol. It's not for those with unstable vital signs, head injuries that prevent EEG placement, prisoners, employees or students at study sites, people with dementia or mental impairments, or skin conditions on the forehead.Check my eligibility
What is being tested?
The study is observing brain activity through EEG monitoring in patients suspected of drug overdose. The goal is to see if different substances affect brain waves in a way that could help doctors quickly identify what someone has taken.See study design
What are the potential side effects?
Since this is an observational study involving non-invasive EEG monitoring, there are minimal side effects expected. However, some discomfort from wearing the EEG leads on the forehead might occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 or older and suspected of using drugs.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Electroencephalography
Trial Design
1Treatment groups
Experimental Treatment
Group I: Observational EEG MonitoringExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,918 Previous Clinical Trials
13,192,825 Total Patients Enrolled
4 Trials studying Substance Abuse
113,866 Patients Enrolled for Substance Abuse
Brigham and Women's HospitalOTHER
1,599 Previous Clinical Trials
11,462,504 Total Patients Enrolled
1 Trials studying Substance Abuse
84 Patients Enrolled for Substance Abuse
Patrick L Purdon, Ph.D.Principal InvestigatorMassachusetts General Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 or older and suspected of using drugs.I have skin problems on my forehead.You have a known condition that affects your memory or thinking abilities, such as dementia or mental impairment.
Research Study Groups:
This trial has the following groups:- Group 1: Observational EEG Monitoring
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger